E-resources
PDF-
Dickerman, Barbra A; Gerlovin, Hanna; Madenci, Arin L; Kurgansky, Katherine E; Ferolito, Brian R; Figueroa Muñiz, Michael J; Gagnon, David R; Gaziano, J. Michael; Cho, Kelly; Casas, Juan P; Hernán, Miguel A
The New England journal of medicine, 01/2022, Volume: 386, Issue: 2Journal Article
In an observational study involving nearly 440,000 veterans, both the BNT162b2 vaccine and the mRNA-1273 vaccine were highly effective at preventing infection, hospitalization, and death from Covid-19. Infection risks were approximately 21% lower with mRNA-1273 than with BNT162b2. Follow-up included periods when either the alpha variant or the delta variant was dominant.
